Sidley Austin LLP
03/08/2021 | Press release | Distributed by Public on 03/08/2021 07:52
Sidley Advises KKR on Its Investment in Nordic Bioscience
Sidley advised KKR on its investment in Nordic Bioscience, a Danish biomarker development company.
The Sidley team was led by Till Lefranc with support from Jakob Egle and Arjun Sehgal (M&A), and included Peter S. Choi, Jeffrey P Kushan, and Timothy Q. Li (IP Litigation); Helen Middleton (Food, Drug and Medical Device Regulatory); Patrick Harrison, Rosanna Connolly, and Mia Gal (Antitrust/Competition); Oliver Currall and Laurence Wilcock (Tax); and Sven De Knop and Alessandra Moroni (Global Arbitration, Trade and Advocacy).
The Sidley team was led by Till Lefranc with support from Jakob Egle and Arjun Sehgal (M&A), and included Peter S. Choi, Jeffrey P Kushan, and Timothy Q. Li (IP Litigation); Helen Middleton (Food, Drug and Medical Device Regulatory); Patrick Harrison, Rosanna Connolly, and Mia Gal (Antitrust/Competition); Oliver Currall and Laurence Wilcock (Tax); and Sven De Knop and Alessandra Moroni (Global Arbitration, Trade and Advocacy).